[1] Yang SB, Li XL, Li K, et al. The colossal role of H-MnO2-PEG in ischemic stroke. Nanomed Nanotechnol Biol Med, 2021; 33, 102362. doi:  10.1016/j.nano.2021.102362
[2] Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation, 2016; 133, e38−360.
[3] Jiang XY, Andjelkovic AV, Zhu L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol, 2018; 163-164, 144-71.
[4] Wu FF, Han B, Wu SS, et al. Circular RNA TLK1 aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p/TIPARP. J Neurosci, 2019; 39, 7369−93. doi:  10.1523/JNEUROSCI.0299-19.2019
[5] Malekmohammad K, Sewell RDE, Rafieian-Kopaei M. Antioxidants and atherosclerosis: mechanistic aspects. Biomolecules, 2019; 9, 301. doi:  10.3390/biom9080301
[6] Laxone R, Ekeros K, Holm R. Lipid biomarkers for atherosclerosis and cardiovascular diseases.
[7] O'Donnell MJ, Xavier D, Liu LS, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 2010; 376, 112−23. doi:  10.1016/S0140-6736(10)60834-3
[8] Wilson PWF, Bozeman SR, Burton TM, et al. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation, 2008; 118, 124−30. doi:  10.1161/CIRCULATIONAHA.108.772962
[9] Nestel PJ, Straznicky N, Mellett NA, et al. Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. Am J Clin Nutr, 2014; 99, 46−53. doi:  10.3945/ajcn.113.071712
[10] Kulkarni H, Meikle PJ, Mamtani M, et al. Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols. Hypertension, 2013; 62, 621−6. doi:  10.1161/HYPERTENSIONAHA.113.01396
[11] Holmes MV, Millwood IY, Kartsonaki C, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol, 2018; 71, 620−32. doi:  10.1016/j.jacc.2017.12.006
[12] Au A. Metabolomics and lipidomics of ischemic stroke. Adv Clin Chem, 2018; 85, 31−69.
[13] Eggers LF, Schwudke D. Lipid extraction: basics of the methyl-tert-butyl ether extraction. In: Wenk MR. Encyclopedia of Lipidomics. Springer. 2016, 1-3.
[14] Zeleke G, De Baere S, Suleman S, et al. Development and validation of a reliable UHPLC-MS/MS method for simultaneous quantification of macrocyclic lactones in bovine plasma. Molecules, 2022; 27, 998. doi:  10.3390/molecules27030998
[15] Tu J, Yin YD, Xu MM, et al. Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain. Metabolomics, 2018; 14, 5. doi:  10.1007/s11306-017-1304-x
[16] Toledo E, Wang DD, Ruiz-Canela M, et al. Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. Am J Clin Nutr, 2017; 106, 973−83. doi:  10.3945/ajcn.116.151159
[17] Sabogal-Guáqueta AM, Villamil-Ortiz JG, Arias-Londoño JD, et al. Inverse phosphatidylcholine/phosphatidylinositol levels as peripheral biomarkers and phosphatidylcholine/lysophosphatidylethanolamine-phosphatidylserine as hippocampal indicator of postischemic cognitive impairment in rats. Front Neurosci, 2018; 12, 989. doi:  10.3389/fnins.2018.00989
[18] Sun HX, Zhao JY, Zhong D, et al. Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS. PLoS One, 2017; 12, e0189009. doi:  10.1371/journal.pone.0189009
[19] Farooqui AA, Horrocks LA, Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids, 2000; 106, 1−29. doi:  10.1016/S0009-3084(00)00128-6
[20] Su HQ, Rustam YH, Masters CL, et al. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease. J Extracell Vesicles, 2021; 10, e12089. doi:  10.1002/jev2.12089
[21] Hermansson M, Hokynar K, Somerharju P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog Lipid Res, 2011; 50, 240−57. doi:  10.1016/j.plipres.2011.02.004
[22] Farooqui AA, Horrocks LA. Excitotoxicity and neurological disorders: involvement of membrane phospholipids. Int Rev Neurobiol, 1994; 36, 267−323.
[23] Farooqui AA, Horrocks LA. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res Rev, 1991; 16, 171−91. doi:  10.1016/0165-0173(91)90004-R